World news, news around town, tech update 3
Ad
Friday, 11 November 2016
AbbVie's hepatitis C treatment shows promise
(Reuters) - Drugmaker AbbVie Inc said on Friday its experimental fixed-dose combination to treat certain hepatitis C virus patients achieved high sustained viral response (SVR) rates after eight weeks of treatment.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment